Therapeutic Innovation Australia (TIA) has announced their investment of $8.8M towards leading cell and gene therapy development and manufacturing facilities across Australia over the next four years. Sydney Cell and Gene Therapy (Westmead), part of the Sydney Children’s Hospitals Network (SCHN) is one of the lead facilities that will be supported through this investment to continue work in revol...
